Literature DB >> 9071575

Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers.

L D Kowalski1, D G Mutch, T J Herzog, J S Rader, P J Goodfellow.   

Abstract

Mutations in the DNA mismatch repair (MMR) genes MLH1 and MSH2 have been linked to several human cancers which display the replication error (RER) phenotype. Germline mutations in these two genes have been implicated in about 90% of families with hereditary nonpolyposis colorectal cancer (HNPCC). A significant proportion of endometrial cancers, the second most common malignancy of the HNPCC syndrome, also exhibit RER. We screened 125 primary endometrial adenocarcinomas with seven microsatellite markers and identified 25 specimens with RER (20%). We used single-strand conformation variant analysis to search for mutations in MLH1 and MSH2. Direct sequencing of variants revealed only one germline mutation in MLH1 and a single somatic mutation in MSH2. However, six previously unreported sequence polymorphisms in MLH1 were identified. Four of these polymorphisms show clear population-based differences in allele frequency. In addition, a highly informative marker for MLH1 was characterized. The low frequency of mutations in MLH1 and MSH2 in this large series of cancers suggests that other MMR genes are responsible for the RER phenotype in endometrial cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9071575     DOI: 10.1002/(sici)1098-2264(199703)18:3<219::aid-gcc8>3.0.co;2-4

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  hMLH1 promoter hypermethylation in microsatellite instability-positive endometrial carcinoma. Cause or consequence?

Authors:  L H Ellenson
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Lower uterine segment involvement is associated with poor outcomes in early-stage endometrioid endometrial carcinoma.

Authors:  Nora T Kizer; Feng Gao; Saketh Guntupalli; Premal H Thaker; Matthew A Powell; Paul J Goodfellow; David G Mutch; Israel Zighelboim
Journal:  Ann Surg Oncol       Date:  2010-12-22       Impact factor: 5.344

3.  Genetic implications of double primary cancers of the colorectum and endometrium.

Authors:  T Pal; T Flanders; M Mitchell-Lehman; A MacMillan; J S Brunet; S A Narod; W D Foulkes
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

4.  Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families.

Authors:  Shiri Dovrat; Arie Figer; Herma H Fidder; Pavlos Neophytou; Zvi Fireman; Ravit Geva; Jamal Zidan; Dov Flex; Shimon Bar Meir; Eitan Friedman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  An American founder mutation in MLH1.

Authors:  Jerneja Tomsic; Sandya Liyanarachchi; Heather Hampel; Monika Morak; Brittany C Thomas; Victoria M Raymond; Anu Chittenden; Hans K Schackert; Stephen B Gruber; Sapna Syngal; Alessandra Viel; Elke Holinski-Feder; Stephen N Thibodeau; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2011-08-30       Impact factor: 7.396

6.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

Authors:  M Esteller; L Catasus; X Matias-Guiu; G L Mutter; J Prat; S B Baylin; J G Herman
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Lynch syndrome in Tunisia: first description of clinical features and germline mutations.

Authors:  Sana Aissi-Ben Moussa; Amel Moussa; Nadia Kourda; Amel Mezlini; Nabil Abdelli; Farid Zerimech; Taoufik Najjar; Sarah Ben Jilani; Nicole Porchet; Farhat Ben Ayed; Mohamed Manai; Marie-Pierre Buisine
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

8.  Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.

Authors:  Paul J Goodfellow; Barbara M Buttin; Thomas J Herzog; Janet S Rader; Randall K Gibb; Elizabeth Swisher; Katherine Look; Ken C Walls; Ming-Yu Fan; David G Mutch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

9.  Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.

Authors:  Ashley S Case; Israel Zighelboim; David G Mutch; Sheri A Babb; Amy P Schmidt; Alison J Whelan; Stephen N Thibodeau; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2007-11-26       Impact factor: 5.482

10.  Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing.

Authors:  Katherine E Varley; David G Mutch; Tina B Edmonston; Paul J Goodfellow; Robi D Mitra
Journal:  Nucleic Acids Res       Date:  2009-06-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.